The global market for Prostate Cancer Antigen 3 Test was valued at US$ 55.6 million in the year 2024 and is projected to reach a revised size of US$ 101 million by 2031, growing at a CAGR of 9.1% during the forecast period.

Prostate Cancer Antigen 3 Test Market

The prostate cancer antigen 3 gene (PCA3) test is used to assess your risk of developing prostate cancer. It is not used to make a diagnosis of prostate cancer. It is primarily used to determine whether your elevated prostate-specific antigen (PSA) levels are the result of prostate cancer. Prostate cancer is a type of cancer that develops in the prostate gland of men and is increasing at a significant rate each year. This cancer is commonly found in the elderly population, and it can have serious consequences such as blood in the sperm, bone pain, and erectile dysfunction, among others. As a result, early detection is required to avoid it at an early stage.

The Global key players of Prostate Cancer Antigen 3 Test include Hologic, Thermo Fisher Scientific, MDxHealth, etc. The top three players hold a share about 77%. US & Canada is the largest market, and has a share about 37%. In terms of product type, RT-PCR is the largest segment, which occupied for a share of about 87%. For application, Hospital is the largest segment, which has a share about 61%.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Antigen 3 Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Antigen 3 Test.

The Prostate Cancer Antigen 3 Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Antigen 3 Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Antigen 3 Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate Cancer Antigen 3 Test Market Report

Report Metric	Details
Report Name	Prostate Cancer Antigen 3 Test Market
Accounted market size in year	US$ 55.6 million
Forecasted market size in 2031	US$ 101 million
CAGR	9.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	RT-PCR ELISA Test
Segment by Application	Hospital Diagnosis Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hologic, Thermo Fisher Scientific, MDxHealth, Exosome Diagnostics GmbH, Copyright Creative Diagnostics, Lytech, YUBO, MicroDiag Biomedicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Antigen 3 Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prostate Cancer Antigen 3 Test Market growing?

Ans: The Prostate Cancer Antigen 3 Test Market witnessing a CAGR of 9.1% during the forecast period 2025-2031.

What is the Prostate Cancer Antigen 3 Test Market size in 2031?

Ans: The Prostate Cancer Antigen 3 Test Market size in 2031 will be US$ 101 million.

What is the market share of major companies in Prostate Cancer Antigen 3 Test Market?

Ans: The top three players hold a share about 77%.

What is the Prostate Cancer Antigen 3 Test Market share by region?

Ans: US & Canada is the largest market, and has a share about 37%.

What is the Prostate Cancer Antigen 3 Test Market share by type?

Ans: In terms of product type, RT-PCR is the largest segment, which occupied for a share of about 87%.

What is the Prostate Cancer Antigen 3 Test Market share by application?

Ans: For application, Hospital is the largest segment, which has a share about 61%.

Who are the main players in the Prostate Cancer Antigen 3 Test Market report?

Ans: The main players in the Prostate Cancer Antigen 3 Test Market are Hologic, Thermo Fisher Scientific, MDxHealth, Exosome Diagnostics GmbH, Copyright Creative Diagnostics, Lytech, YUBO, MicroDiag Biomedicine

What are the Application segmentation covered in the Prostate Cancer Antigen 3 Test Market report?

Ans: The Applications covered in the Prostate Cancer Antigen 3 Test Market report are Hospital, Diagnosis Center, Other

What are the Type segmentation covered in the Prostate Cancer Antigen 3 Test Market report?

Ans: The Types covered in the Prostate Cancer Antigen 3 Test Market report are RT-PCR, ELISA Test

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Antigen 3 Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 RT-PCR

1.2.3 ELISA Test

1.3 Market by Application

1.3.1 Global Prostate Cancer Antigen 3 Test Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Diagnosis Center

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Antigen 3 Test Market Perspective (2020-2031)

2.2 Global Prostate Cancer Antigen 3 Test Growth Trends by Region

2.2.1 Global Prostate Cancer Antigen 3 Test Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Prostate Cancer Antigen 3 Test Historic Market Size by Region (2020-2025)

2.2.3 Prostate Cancer Antigen 3 Test Forecasted Market Size by Region (2026-2031)

2.3 Prostate Cancer Antigen 3 Test Market Dynamics

2.3.1 Prostate Cancer Antigen 3 Test Industry Trends

2.3.2 Prostate Cancer Antigen 3 Test Market Drivers

2.3.3 Prostate Cancer Antigen 3 Test Market Challenges

2.3.4 Prostate Cancer Antigen 3 Test Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Antigen 3 Test Players by Revenue

3.1.1 Global Top Prostate Cancer Antigen 3 Test Players by Revenue (2020-2025)

3.1.2 Global Prostate Cancer Antigen 3 Test Revenue Market Share by Players (2020-2025)

3.2 Global Prostate Cancer Antigen 3 Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Prostate Cancer Antigen 3 Test Revenue

3.4 Global Prostate Cancer Antigen 3 Test Market Concentration Ratio

3.4.1 Global Prostate Cancer Antigen 3 Test Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Antigen 3 Test Revenue in 2024

3.5 Global Key Players of Prostate Cancer Antigen 3 Test Head office and Area Served

3.6 Global Key Players of Prostate Cancer Antigen 3 Test, Product and Application

3.7 Global Key Players of Prostate Cancer Antigen 3 Test, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Antigen 3 Test Breakdown Data by Type

4.1 Global Prostate Cancer Antigen 3 Test Historic Market Size by Type (2020-2025)

4.2 Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Type (2026-2031)

5 Prostate Cancer Antigen 3 Test Breakdown Data by Application

5.1 Global Prostate Cancer Antigen 3 Test Historic Market Size by Application (2020-2025)

5.2 Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Prostate Cancer Antigen 3 Test Market Size (2020-2031)

6.2 North America Prostate Cancer Antigen 3 Test Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Prostate Cancer Antigen 3 Test Market Size by Country (2020-2025)

6.4 North America Prostate Cancer Antigen 3 Test Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Antigen 3 Test Market Size (2020-2031)

7.2 Europe Prostate Cancer Antigen 3 Test Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Prostate Cancer Antigen 3 Test Market Size by Country (2020-2025)

7.4 Europe Prostate Cancer Antigen 3 Test Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Antigen 3 Test Market Size (2020-2031)

8.2 Asia-Pacific Prostate Cancer Antigen 3 Test Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Prostate Cancer Antigen 3 Test Market Size by Region (2020-2025)

8.4 Asia-Pacific Prostate Cancer Antigen 3 Test Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Antigen 3 Test Market Size (2020-2031)

9.2 Latin America Prostate Cancer Antigen 3 Test Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2020-2025)

9.4 Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size (2020-2031)

10.2 Middle East & Africa Prostate Cancer Antigen 3 Test Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Country (2020-2025)

10.4 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Hologic

11.1.1 Hologic Company Details

11.1.2 Hologic Business Overview

11.1.3 Hologic Prostate Cancer Antigen 3 Test Introduction

11.1.4 Hologic Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025)

11.1.5 Hologic Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Prostate Cancer Antigen 3 Test Introduction

11.2.4 Thermo Fisher Scientific Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 MDxHealth

11.3.1 MDxHealth Company Details

11.3.2 MDxHealth Business Overview

11.3.3 MDxHealth Prostate Cancer Antigen 3 Test Introduction

11.3.4 MDxHealth Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025)

11.3.5 MDxHealth Recent Development

11.4 Exosome Diagnostics GmbH

11.4.1 Exosome Diagnostics GmbH Company Details

11.4.2 Exosome Diagnostics GmbH Business Overview

11.4.3 Exosome Diagnostics GmbH Prostate Cancer Antigen 3 Test Introduction

11.4.4 Exosome Diagnostics GmbH Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025)

11.4.5 Exosome Diagnostics GmbH Recent Development

11.5 Copyright Creative Diagnostics

11.5.1 Copyright Creative Diagnostics Company Details

11.5.2 Copyright Creative Diagnostics Business Overview

11.5.3 Copyright Creative Diagnostics Prostate Cancer Antigen 3 Test Introduction

11.5.4 Copyright Creative Diagnostics Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025)

11.5.5 Copyright Creative Diagnostics Recent Development

11.6 Lytech

11.6.1 Lytech Company Details

11.6.2 Lytech Business Overview

11.6.3 Lytech Prostate Cancer Antigen 3 Test Introduction

11.6.4 Lytech Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025)

11.6.5 Lytech Recent Development

11.7 YUBO

11.7.1 YUBO Company Details

11.7.2 YUBO Business Overview

11.7.3 YUBO Prostate Cancer Antigen 3 Test Introduction

11.7.4 YUBO Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025)

11.7.5 YUBO Recent Development

11.8 MicroDiag Biomedicine

11.8.1 MicroDiag Biomedicine Company Details

11.8.2 MicroDiag Biomedicine Business Overview

11.8.3 MicroDiag Biomedicine Prostate Cancer Antigen 3 Test Introduction

11.8.4 MicroDiag Biomedicine Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025)

11.8.5 MicroDiag Biomedicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

MDxHealth

Hologic Inc

Thermo Fisher Scientific

Yubo

MicroDiag Biomedicine

Exosome Diagnostics GmbH

Lytech

List of Tables

Table 1. Global Prostate Cancer Antigen 3 Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of RT-PCR

Table 3. Key Players of ELISA Test

Table 4. Global Prostate Cancer Antigen 3 Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Prostate Cancer Antigen 3 Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Prostate Cancer Antigen 3 Test Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Prostate Cancer Antigen 3 Test Market Share by Region (2020-2025)

Table 8. Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Prostate Cancer Antigen 3 Test Market Share by Region (2026-2031)

Table 10. Prostate Cancer Antigen 3 Test Market Trends

Table 11. Prostate Cancer Antigen 3 Test Market Drivers

Table 12. Prostate Cancer Antigen 3 Test Market Challenges

Table 13. Prostate Cancer Antigen 3 Test Market Restraints

Table 14. Global Prostate Cancer Antigen 3 Test Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Prostate Cancer Antigen 3 Test Market Share by Players (2020-2025)

Table 16. Global Top Prostate Cancer Antigen 3 Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Antigen 3 Test as of 2024)

Table 17. Ranking of Global Top Prostate Cancer Antigen 3 Test Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Prostate Cancer Antigen 3 Test Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Prostate Cancer Antigen 3 Test, Headquarters and Area Served

Table 20. Global Key Players of Prostate Cancer Antigen 3 Test, Product and Application

Table 21. Global Key Players of Prostate Cancer Antigen 3 Test, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prostate Cancer Antigen 3 Test Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2020-2025)

Table 25. Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2026-2031)

Table 27. Global Prostate Cancer Antigen 3 Test Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2020-2025)

Table 29. Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2026-2031)

Table 31. North America Prostate Cancer Antigen 3 Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Prostate Cancer Antigen 3 Test Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Prostate Cancer Antigen 3 Test Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Prostate Cancer Antigen 3 Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Prostate Cancer Antigen 3 Test Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Prostate Cancer Antigen 3 Test Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Prostate Cancer Antigen 3 Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Prostate Cancer Antigen 3 Test Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Antigen 3 Test Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Prostate Cancer Antigen 3 Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Prostate Cancer Antigen 3 Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Country (2026-2031) & (US$ Million)

Table 46. Hologic Company Details

Table 47. Hologic Business Overview

Table 48. Hologic Prostate Cancer Antigen 3 Test Product

Table 49. Hologic Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025) & (US$ Million)

Table 50. Hologic Recent Development

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific Prostate Cancer Antigen 3 Test Product

Table 54. Thermo Fisher Scientific Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. MDxHealth Company Details

Table 57. MDxHealth Business Overview

Table 58. MDxHealth Prostate Cancer Antigen 3 Test Product

Table 59. MDxHealth Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025) & (US$ Million)

Table 60. MDxHealth Recent Development

Table 61. Exosome Diagnostics GmbH Company Details

Table 62. Exosome Diagnostics GmbH Business Overview

Table 63. Exosome Diagnostics GmbH Prostate Cancer Antigen 3 Test Product

Table 64. Exosome Diagnostics GmbH Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025) & (US$ Million)

Table 65. Exosome Diagnostics GmbH Recent Development

Table 66. Copyright Creative Diagnostics Company Details

Table 67. Copyright Creative Diagnostics Business Overview

Table 68. Copyright Creative Diagnostics Prostate Cancer Antigen 3 Test Product

Table 69. Copyright Creative Diagnostics Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025) & (US$ Million)

Table 70. Copyright Creative Diagnostics Recent Development

Table 71. Lytech Company Details

Table 72. Lytech Business Overview

Table 73. Lytech Prostate Cancer Antigen 3 Test Product

Table 74. Lytech Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025) & (US$ Million)

Table 75. Lytech Recent Development

Table 76. YUBO Company Details

Table 77. YUBO Business Overview

Table 78. YUBO Prostate Cancer Antigen 3 Test Product

Table 79. YUBO Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025) & (US$ Million)

Table 80. YUBO Recent Development

Table 81. MicroDiag Biomedicine Company Details

Table 82. MicroDiag Biomedicine Business Overview

Table 83. MicroDiag Biomedicine Prostate Cancer Antigen 3 Test Product

Table 84. MicroDiag Biomedicine Revenue in Prostate Cancer Antigen 3 Test Business (2020-2025) & (US$ Million)

Table 85. MicroDiag Biomedicine Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Prostate Cancer Antigen 3 Test Picture

Figure 2. Global Prostate Cancer Antigen 3 Test Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Prostate Cancer Antigen 3 Test Market Share by Type: 2024 VS 2031

Figure 4. RT-PCR Features

Figure 5. ELISA Test Features

Figure 6. Global Prostate Cancer Antigen 3 Test Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Prostate Cancer Antigen 3 Test Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Diagnosis Center Case Studies

Figure 10. Other Case Studies

Figure 11. Prostate Cancer Antigen 3 Test Report Years Considered

Figure 12. Global Prostate Cancer Antigen 3 Test Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Prostate Cancer Antigen 3 Test Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Prostate Cancer Antigen 3 Test Market Share by Region: 2024 VS 2031

Figure 15. Global Prostate Cancer Antigen 3 Test Market Share by Players in 2024

Figure 16. Global Top Prostate Cancer Antigen 3 Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Antigen 3 Test as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Antigen 3 Test Revenue in 2024

Figure 18. North America Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Prostate Cancer Antigen 3 Test Market Share by Country (2020-2031)

Figure 20. United States Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Prostate Cancer Antigen 3 Test Market Share by Country (2020-2031)

Figure 24. Germany Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Prostate Cancer Antigen 3 Test Market Share by Region (2020-2031)

Figure 32. China Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Prostate Cancer Antigen 3 Test Market Share by Country (2020-2031)

Figure 40. Mexico Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Prostate Cancer Antigen 3 Test Market Share by Country (2020-2031)

Figure 44. Turkey Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Prostate Cancer Antigen 3 Test Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Hologic Revenue Growth Rate in Prostate Cancer Antigen 3 Test Business (2020-2025)

Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Antigen 3 Test Business (2020-2025)

Figure 49. MDxHealth Revenue Growth Rate in Prostate Cancer Antigen 3 Test Business (2020-2025)

Figure 50. Exosome Diagnostics GmbH Revenue Growth Rate in Prostate Cancer Antigen 3 Test Business (2020-2025)

Figure 51. Copyright Creative Diagnostics Revenue Growth Rate in Prostate Cancer Antigen 3 Test Business (2020-2025)

Figure 52. Lytech Revenue Growth Rate in Prostate Cancer Antigen 3 Test Business (2020-2025)

Figure 53. YUBO Revenue Growth Rate in Prostate Cancer Antigen 3 Test Business (2020-2025)

Figure 54. MicroDiag Biomedicine Revenue Growth Rate in Prostate Cancer Antigen 3 Test Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Prostate Specific Antigen PSA Biomarker Market Insights Forecast to 2030

Global Prostate Specific Antigen PSA Blood Based Biomarker Market Insights Forecast to 2030

Prostate Specific Antigen PSA Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PSA Test Market Insights Forecast to 2030

Global One Step Prostate Specific Antigen Test Kit Market Research Report 2024

Global Prostate Cancer Test Kit Market Research Report 2025

Prostate Specific Antigen Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rapid Prostate Cancer Tests Market Research Report 2024

Global Prostate Specific Antigen PSA Semi Qualitative Kit Market Research Report 2024

Global Prostate Specific Antigen Market Research Report 2024

Global PSMA Antibody Market Research Report 2024

Global HPV DNA Test Market Insights Forecast to 2030

Gene Expression Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Global Cancer Rapid Diagnostic Test Box Market Research Report 2025

Prostate Specific Antigen Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Market Insights Forecast to 2030

Global Prostate Cancer Diagnostics Solution Market Research Report 2025

Cancer Diagnostic Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions